Pharmaceutical Information |
Drug Name |
Cefaclor |
Drug ID |
BADD_D00378 |
Description |
Semisynthetic, broad-spectrum antibiotic derivative of cephalexin. |
Indications and Usage |
For the treatment of certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections. |
Marketing Status |
approved |
ATC Code |
J01DC04 |
DrugBank ID |
DB00833
|
KEGG ID |
D00256; D02352
|
MeSH ID |
D002433
|
PubChem ID |
51039
|
TTD Drug ID |
D0PW7C
|
NDC Product Code |
0093-1087; 23594-250; 23594-375; 23594-125; 61442-171; 61442-172; 81948-6250 |
UNII |
69K7K19H4L
|
Synonyms |
Cefaclor | Cefaclor Anhydrous | Keclor | 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6alpha,7beta(R*)))- | S-6472 | S 6472 | S6472 | Ceclor | Cefaclor Monohydrate | Lilly 99638 |
|
Chemical Information |
Molecular Formula |
C15H14ClN3O4S |
CAS Registry Number |
53994-73-3 |
SMILES |
C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl |
Chemical Structure |
|
|
ADRs Induced by Drug |
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|